Viral Load as a Primary Outcome in Human Immunodeficiency Virus Trials
- 29 November 2001
- journal article
- review article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 22 (6), 639-658
- https://doi.org/10.1016/s0197-2456(01)00158-1
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Antiretroviral Therapy in AdultsJAMA, 2000
- Analysis of HIV-1 clinical trials: statistical magic?The Lancet, 1999
- HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: an extended virology studyAIDS, 1999
- Statistical issues for HIV surrogate endpoints: point/counterpointStatistics in Medicine, 1998
- Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependentAIDS, 1998
- Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral TherapyThe Journal of Infectious Diseases, 1998
- Longitudinal models for AIDS marker dataStatistical Methods in Medical Research, 1998
- Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic ResponseAnnals of Internal Medicine, 1997
- Use of Virologic Markers in Clinical PracticeJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996